The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[14C]-6-tert-butyl-2-(2-(hydroxymethyl)-3-(1-methyl-5-(5-(morpholine-4-carbonyl)pyridin-2-ylamino)-6-oxo-1,6-dihydropyridin-3-yl)phenyl)-3,4-dihydroisoquinolin-1(2H)-one ID: ALA4098685
PubChem CID: 137659731
Max Phase: Preclinical
Molecular Formula: C36H39N5O5
Molecular Weight: 621.74
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(-c2cccc(N3CCc4cc(C(C)(C)C)ccc4C3=O)c2[14CH2]O)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O
Standard InChI: InChI=1S/C36H39N5O5/c1-36(2,3)26-9-10-28-23(18-26)12-13-41(34(28)44)31-7-5-6-27(29(31)22-42)25-19-30(35(45)39(4)21-25)38-32-11-8-24(20-37-32)33(43)40-14-16-46-17-15-40/h5-11,18-21,42H,12-17,22H2,1-4H3,(H,37,38)/i22+2
Standard InChI Key: HCJJXHLWABHYMG-FSEIIBCTSA-N
Molfile:
RDKit 2D
46 51 0 0 0 0 0 0 0 0999 V2000
5.6902 -20.9038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6890 -21.7311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4038 -22.1440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1202 -21.7306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1174 -20.9002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4020 -20.4910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8278 -20.4851 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5436 -20.8971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5397 -19.2481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8226 -19.6614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2556 -19.6601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2514 -20.4854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9629 -20.8997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6791 -20.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6792 -19.6615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9670 -19.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5454 -21.7220 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3995 -19.6660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1127 -19.2514 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9763 -20.4916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9781 -19.6656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2676 -19.2534 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5509 -19.6626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5490 -20.4885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2641 -20.9053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2706 -18.4284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8378 -19.2476 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8333 -20.8988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8306 -21.7238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1147 -22.1291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1117 -22.9533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8254 -23.3689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5435 -22.9543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5430 -22.1314 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3936 -19.2488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1081 -19.6611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3934 -18.4238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1040 -18.8288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8239 -24.1939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1086 -24.6051 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5375 -24.6077 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5385 -25.4294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2481 -25.8431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9657 -25.4354 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9693 -24.6094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2551 -24.1912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
7 10 1 0
8 12 1 0
11 9 1 0
9 10 1 0
5 7 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
8 17 2 0
6 18 1 0
18 19 1 0
20 21 2 0
20 25 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 2 0
1 20 1 0
22 26 1 0
23 27 2 0
24 28 1 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 29 1 0
15 35 1 0
35 36 1 0
35 37 1 0
35 38 1 0
32 39 1 0
39 40 2 0
39 41 1 0
41 42 1 0
41 46 1 0
42 43 1 0
43 44 1 0
44 45 1 0
45 46 1 0
M ISO 1 18 14
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 621.74Molecular Weight (Monoisotopic): 621.2951AlogP: 4.66#Rotatable Bonds: 6Polar Surface Area: 117.00Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.38CX Basic pKa: 3.94CX LogP: 3.17CX LogD: 3.17Aromatic Rings: 4Heavy Atoms: 46QED Weighted: 0.32Np Likeness Score: -0.99
References 1. Lou Y, Lopez F, Jiang Y, Han X, Brotherton C, Billedeau R, Gabriel S, Gleason S, Goldstein DM, Hilgenkamp R, Kocer B, Orzechowski L, Tan J, Wovkulich P, Wen B, Fry D, Di Lello P, Chen L, Zhang FJ, Fretland J, Nangia A, Yang T, Owens TD.. (2017) Mitigation of reactive metabolite formation for a series of 3-amino-2-pyridone inhibitors of Bruton's tyrosine kinase (BTK)., 27 (3): [PMID:28025004 ] [10.1016/j.bmcl.2016.11.092 ]